Sfoglia per AUTORE
ROSSI D
Collezione AOU Novara

  

Items : 46

A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA. in Blood / Blood. 2025 May 13:blood.2024027355. doi: 10.1182/blood.2024027355.
2025
AOU Novara

Pirosa MC; Bruscaggin A; Terzi di Bergamo L; Salehi M; Jauk F; Forestieri G; Bocchetta S; Piffaretti D; Moia R; Cristaldi V; di Trani M; Galimberti GA; Pini K; Spina V; Giordano C; Condoluci A; Romano I; Annunziata S; Bergesio F; Boldorini R; Borsatti E; Bulian P; Calabretta E; Chauvie S; Corrado F; Crisci S; Cuzzocrea M; De Filippi R; Gerber B; et alii...

The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia. in American journal of hematology / Am J Hematol. 2023 Jul;98(7):E157-E160. doi: 10.1002/ajh.26927. Epub 2023 Apr 17.
2023
AOU Novara

Morabito F; Tripepi G; Mauro FR; Laurenti L; Reda G; Moia R; Condoluci A; Vincelli I; Chiarenza A; Vigna E; Martino EA; Bruzzese A; Mezzatesta S; Laureana R; Cutrona G; Di Raimondo F; Fronza G; Zucchetto A; Bomben R; Rossi FM; Olivieri J; Zaja F; Rossi D; Gaidano G; Del Principe MI; Ilariucci F; Del Poeta G; Ferrarini M; Neri A; et alii...

2023
AOU Città della Salute di Torino
AOU Novara

Herishanu Y; Perry C; Gattei V; Cuneo A; Foà R; Gaidano G; Trentin L; Rossi D; Neri A; Olivieri J; Zucchetto A; Bomben R; Pietrasanta D; Loseto G; Chiarenza A; Visentin A; Aviv A; Murru R; Braester A; Varettoni M; Coscia M; Tadmor T; Shvidel L; Laurenti L; Reda G; Ruchlemer R; Sportoletti P; Mauro FR; Gutwein O; et alii...

Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):567-570. doi: 10.1002/hon.3080. Epub 2022 Oct 10.
2023
AOU Novara

Moia R; Dondolin R; De Propris MS; Talotta D; Mouhssine S; Perutelli F; Reda G; Mattiello V; Rigolin GM; Motta M; Olivieri J; Fanin R; Perbellini O; Ferrarini I; Mauro FR; Del Giudice I; Laurenti L; Tomasso A; Gentile M; Frustaci AM; Tedeschi A; Gozzetti A; Stelitano C; Visco C; Moreno C; Forconi F; Marasca R; Coscia M; Rossi D; et alii...

Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma. in British journal of haematology / Br J Haematol. 2021 Oct;195(1):108-112. doi: 10.1111/bjh.17718. Epub 2021 Jul 22.
2021
AOU Novara

Moia R; Favini C; Ferri V; Forestieri G; Terzi Di Bergamo L; Schipani M; Sagiraju S; Andorno A; Rasi S; Adhinaveni R; Talotta D; Al Essa W; De Paoli L; Margiotta Casaluci G; Patriarca A; Boldorini RL; Rossi D; Gaidano G;

Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. in American journal of hematology / Am J Hematol. 2021 May 1;96(5):E168-E171. doi: 10.1002/ajh.26127. Epub 2021 Feb 24.
2021
AOU Città della Salute di Torino
AOU Novara

Gattei V; Foà R; Ferrarini M; Trentin L; Polliack A; Gaidano G; Cuneo A; Di Raimondo F; Rossi D; Fronza G; Cutrona G; Neri A; Bomben R; Del Giudice I; Biagi A; Angeletti I; Rago A; D'Arrigo G; Galimberti S; Cassin R; Botta C; Caracciolo D; Mendicino F; Vigna E; Martino EA; Zucchetto A; Rossi FM; Scortechini I; Loseto G; et alii...

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. in Blood / Blood. 2021 Mar 11;137(10):1365-1376. doi: 10.1182/blood.2020007039.
2021
AOU Novara

Agathangelidis A; Chatzidimitriou A; Gemenetzi K; Giudicelli V; Karypidou M; Plevova K; Davis Z; Yan XJ; Jeromin S; Schneider C; Pedersen LB; Tschumper RC; Sutton LA; Baliakas P; Scarfò L; van Gastel EJ; Armand M; Tausch E; Biderman B; Baer C; Bagnara D; Navarro A; Langlois de Septenville A; Guido V; Mitterbauer-Hohendanner G; Dimovski A; Brieghel C; Lawless S; Meggendorfer M; et alii...

Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study. in Leukemia / Leukemia. 2021 Jan;35(1):235-238. doi: 10.1038/s41375-020-0833-x. Epub 2020 Apr 14.
2021
AOU Città della Salute di Torino
AOU Novara

Gattei V; Cuneo A; Foà R; Polliack A; Gaidano G; Di Raimondo F; Bomben R; Rossi D; Rigolin GM; Del Giudice I; Biagi A; Arrigo G; Rago A; Angeletti I; Botta C; Tripepi G; Vigna E; Fraticelli V; Rossi FM; Zucchetto A; Scortechini I; Consoli U; Pietrasanta D; Loseto G; Moia R; Chiarenza A; Condoluci A; Murru R; Varettoni M; et alii...

TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):E306-E310. doi: 10.1002/ajh.26235. Epub 2021 May 25.
2021
AOU Città della Salute di Torino
AOU Novara

Ferrarini M; Foà R; Trentin L; Polliack A; Gaidano G; Cuneo A; Olivieri J; Rossi D; Di Raimondo F; Cutrona G; Jaksic O; Fronza G; Neri A; Bomben R; Biagi A; Del Giudice I; Angeletti I; Galimberti S; Rago A; D'Arrigo G; Vigna E; Tripepi G; Martino EA; Al-Janazreh H; Zucchetto A; Rossi FM; Consoli U; Scortechini I; Recchia AG; et alii...

2021
AOU Città della Salute di Torino
AOU Novara

Ferrarini M; Trentin L; Foà R; Polliack A; Di Raimondo F; Gaidano G; Cuneo A; Rossi D; Cutrona G; Olivieri J; Menichini P; Monti P; Neri A; Fronza G; Bomben R; Del Giudice I; Angeletti I; Biagi A; Galimberti S; Rago A; D Arrigo G; Martino EA; Cassin R; Vigna E; Al-Janazreh H; Rossi FM; Zucchetto A; Scortechini I; Consoli U; et alii...

Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases. in European journal of haematology / Eur J Haematol. 2021 Apr;106(4):493-499. doi: 10.1111/ejh.13573. Epub 2021 Jan 28.
2021
AOU Città della Salute di Torino
AOU Novara

Ferrarini M; Foà R; Trentin L; Polliack A; Gaidano G; Cuneo A; Di Raimondo F; Rossi D; Jaksic O; Cutrona G; Menichini P; Fronza G; Monti P; Neri A; Del Giudice I; Bomben R; Biagi A; Rago A; Angeletti I; D'Arrigo G; Galimberti S; Mendicino F; Cassin R; Martino EA; Vigna E; Al-Janazreh H; Zucchetto A; Scortechini I; Rossi FM; et alii...

Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia. in Frontiers in oncology / Front Oncol. 2021 Aug 2;11:684621. doi: 10.3389/fonc.2021.684621. eCollection 2021.
2021
AOU Novara

Morabito F; Tripepi G; Moia R; Recchia AG; Boggione P; Mauro FR; Bossio S; D'Arrigo G; Martino EA; Vigna E; Storino F; Fronza G; Di Raimondo F; Rossi D; Condoluci A; Colombo M; Fais F; Fabris S; Foa R; Cutrona G; Gentile M; Montserrat E; Gaidano G; Ferrarini M; Neri A;

2020
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Ghia P; Cuneo A; Foà R; Montserrat E; Rambaldi A; Rossi G; Stamatopoulos K; Coscia M; Tam C; Zdrenghea M; Strugov V; Stavroyianni N; Stanca O; Shrestha A; Shah N; Rossi D; Papaioannou M; Ortiz Pareja M; Kalashnikova O; Enrico A; Hakobyan Y; Doubek M; Dimou M; Andres M; Nikitin E; Dos Santos G; Chiarenza A; Barna G; Pocali B; et alii...

Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients. in Hematological oncology / Hematol Oncol. 2020 Aug;38(3):406-408. doi: 10.1002/hon.2722. Epub 2020 Feb 25.
2020
AOU Novara

Lionetti M; Barbieri M; Favasuli V; Taiana E; Fabris S; Favoino C; Ciceri G; Matis S; Colombo M; Massara R; Reda G; Gentile M; Spina V; Rossi D; Baldini L; Gaidano G; Fais F; Ferrarini M; Morabito F; Cutrona G; Neri A;

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Jan 31;105(2):448-456. doi: 10.3324/haematol.2019.219550. Print 2020.
2020
AOU Città della Salute di Torino
AOU Novara

Rossi D; Gaidano G; Foà R; Deaglio S; Catherwood M; Boldorini RL; Gattei V; Cuneo A; Follenzi A; Poeta GD; Bertoni F; Lawless S; Thornton P; Mills K; Donaldson D; Weir P; Motta M; Laurenti L; Tedeschi A; Perbellini O; Coscia M; Marasca R; Rigolin GM; Chiarenza A; Visco C; Rossi FM; Bomben R; Cortelezzi A; Zaja F; et alii...

Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome. in British journal of haematology / Br J Haematol. 2019 Nov;187(4):478-487. doi: 10.1111/bjh.16106. Epub 2019 Aug 5.
2019
AOU Novara

Vannata B; Conconi A; Winkler J; Cascione L; Margiotta Casaluci G; Nassi L; Moia R; Pirosa MC; Moccia AA; Stathis A; Rossi D; Gaidano G; Zucca E;

2018
AOU Novara

Morabito F; Shanafelt TD; Gentile M; Reda G; Mauro FR; Rossi D; Di Renzo N; Molica S; Angrilli F; Chiarenza A; Cutrona G; Chaffee KG; Parikh SA; Tripepi G; D'Arrigo G; Vigna E; Recchia AG; Cortelezzi A; Gaidano G; Di Raimondo F; Fais F; Foà R; Neri A; Ferrarini M;

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma. in Blood / Blood. 2018 May 31;131(22):2413-2425. doi: 10.1182/blood-2017-11-812073. Epub 2018 Feb 15.
2018
AOU Novara

Spina V; Bruscaggin A; Cuccaro A; Martini M; Di Trani M; Forestieri G; Manzoni M; Condoluci A; Arribas A; Terzi-Di-Bergamo L; Locatelli SL; Cupelli E; Ceriani L; Moccia AA; Stathis A; Nassi L; Deambrogi C; Diop F; Guidetti F; Cocomazzi A; Annunziata S; Rufini V; Giordano A; Neri A; Boldorini R; Gerber B; Bertoni F; Ghielmini M; Stüssi G; et alii...

Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment. in European journal of haematology / Eur J Haematol. 2018 Jul 24. doi: 10.1111/ejh.13149.
2018
AOU Città della Salute di Torino
AOU Novara

Morabito F; Foà R; Polliack A; Kay NE; Gaidano G; Ferrarini M; Neri A; Cortelezzi A; Del Poeta G; Di Raimondo F; Recchia AG; Innocenti I; Shvidel L; Zirlik K; Vigna E; Sameer PA; Chaffee KG; Tripepi G; Bairey O; Rago A; Giordano A; Angrilli F; Ciolli S; Goldschmidt N; Molica S; Chiarenza A; Herishanu Y; Coscia M; Angeletti I; et alii...

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases. in American journal of hematology / Am J Hematol. 2018 Feb;93(2):E35-E37. doi: 10.1002/ajh.24960. Epub 2017 Nov 23.
2018
AOU Novara

Gentile M; Shanafelt TD; Mauro FR; Laurenti L; Rossi D; Molica S; Vincelli I; Cutrona G; Uccello G; Pepe S; Vigna E; Tripepi G; Chaffee KG; Parikh SA; Bossio S; Recchia AG; Innocenti I; Pasquale R; Neri A; Ferrarini M; Gaidano G; Foà R; Morabito F;

Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab. in Leukemia / Leukemia. 2018 Aug;32(8):1869-1873. doi: 10.1038/s41375-018-0100-6. Epub 2018 Mar 20.
2018
AOU Città della Salute di Torino
AOU Novara

Morabito F; Polliack A; Foà R; Ferrarini M; Neri A; Di Raimondo F; Gaidano G; Del Poeta G; Cortelezzi A; Tadmor T; Shvidel L; Herishanu Y; Recchia AG; Vigna E; D'Arrigo G; Tripepi G; Innocenti I; Uccello G; Parikh SA; Chaffee KG; Cutrona G; Giordano A; Chiarenza A; Coscia M; Angrilli F; Molica S; Di Renzo N; Rossi D; Del Principe MI; et alii...

Diffuse large B-cell lymphoma genotyping on the liquid biopsy. in Blood / Blood. 2017 Apr 6;129(14):1947-1957. doi: 10.1182/blood-2016-05-719641. Epub 2017 Jan 17.
2017
AOU Novara

Rossi D; Diop F; Spaccarotella E; Monti S; Zanni M; Rasi S; Deambrogi C; Spina V; Bruscaggin A; Favini C; Serra R; Ramponi A; Boldorini R; Foà R; Gaidano G;

The genetics of nodal marginal zone lymphoma. in Blood / Blood. 2016 Sep 8;128(10):1362-73. doi: 10.1182/blood-2016-02-696757. Epub 2016 Jun 22.
2016
AOU Novara

Spina V; Khiabanian H; Messina M; Monti S; Cascione L; Bruscaggin A; Spaccarotella E; Holmes AB; Arcaini L; Lucioni M; Tabbò F; Zairis S; Diop F; Cerri M; Chiaretti S; Marasca R; Ponzoni M; Deaglio S; Ramponi A; Tiacci E; Pasqualucci L; Paulli M; Falini B; Inghirami G; Bertoni F; Foà R; Rabadan R; Gaidano G; Rossi D; et alii...

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients. in Blood / Blood. 2016 Oct 20;128(16):2093-2095. doi: 10.1182/blood-2016-07-728261. Epub 2016 Aug 22.
2016
AOU Novara

Gentile M; Shanafelt TD; Rossi D; Laurenti L; Mauro FR; Molica S; Cutrona G; Uccello G; Campanelli M; Vigna E; Tripepi G; Chaffee KG; Parikh SA; Bossio S; Recchia AG; Innocenti I; Pasquale R; Neri A; Ferrarini M; Gaidano G; Foà R; Morabito F;

2016
AOU Novara

Lionetti M; Barbieri M; Manzoni M; Fabris S; Bandini C; Todoerti K; Nozza F; Rossi D; Musto P; Baldini L; Neri A;

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia. in Blood / Blood. 2015 Oct 15;126(16):1921-4. doi: 10.1182/blood-2015-05-647925. Epub 2015 Aug 14.
2015
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Gaidano G; Gattei V; Foà R; Cuneo A; Montillo M; Massaia M; Zinzani PL; Del Poeta G; Perbellini O; Moreno C; Marasca R; Tedeschi A; Neri A; Motta M; Coscia M; Rigolin GM; Vincelli I; Del Giudice I; Gentile M; Laurenti L; Forconi F; Zaja F; Morabito F; Cortelezzi A; Mauro FR; Visco C; Chiarenza A; Bulian P; Ghilardi G; et alii...

Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience. in American journal of hematology / Am J Hematol. 2015 Nov;90(11):970-4. doi: 10.1002/ajh.24127. Epub 2015 Aug 14.
2015
AOU Novara

Sciumè M; Vincenti D; Reda G; Orofino N; Cassin R; Giannarelli D; Gaidano G; Rossi D; Cortelezzi A;

DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features. in Blood / Blood. 2015 Mar 19;125(12):1922-31. doi: 10.1182/blood-2014-08-596247. Epub 2015 Jan 22.
2015
AOU Novara

Arribas AJ; Rinaldi A; Mensah AA; Kwee I; Cascione L; Robles EF; Martinez-Climent JA; Oscier D; Arcaini L; Baldini L; Marasca R; Thieblemont C; Briere J; Forconi F; Zamò A; Bonifacio M; Mollejo M; Facchetti F; Dirnhofer S; Ponzoni M; Bhagat G; Piris MA; Gaidano G; Zucca E; Rossi D; Bertoni F;

The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. in Leukemia / Leukemia. 2015 Feb;29(2):503-7. doi: 10.1038/leu.2014.294. Epub 2014 Oct 6.
2015
AOU Novara

Piva R; Deaglio S; Famà R; Buonincontri R; Scarfò I; Bruscaggin A; Mereu E; Serra S; Spina V; Brusa D; Garaffo G; Monti S; Dal Bo M; Marasca R; Arcaini L; Neri A; Gattei V; Paulli M; Tiacci E; Bertoni F; Pileri SA; Foà R; Inghirami G; Gaidano G; Rossi D;

A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients. in Haematologica / Haematologica. 2015 Dec;100(12):e501-4. doi: 10.3324/haematol.2015.132035. Epub 2015 Aug 20.
2015
AOU Città della Salute di Torino
AOU Novara

Rambaldi A; Orlandi E; Picardi P; De Paoli L; Dalceggio D; Frustaci AM; Cairoli R; Scarfò L; Nador G; Cortelezzi A; Rossini F; Anastasia A; Coscia M; Rossi M; Quaresmini G; Motta M; Rossi D; Tedeschi A; Massaia M; Gaidano G; Montillo M;

Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia. in Leukemia & lymphoma / Leuk Lymphoma. 2015;56(11):3150-8. doi: 10.3109/10428194.2015.1028051. Epub 2015 May 18.
2015
AOU Novara

Maura F; Cutrona G; Mosca L; Matis S; Lionetti M; Fabris S; Agnelli L; Colombo M; Massucco C; Ferracin M; Zagatti B; Reverberi D; Gentile M; Recchia AG; Bossio S; Rossi D; Gaidano G; Molica S; Cortelezzi A; Di Raimondo F; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A;

Merkel cell carcinoma arising in inguinal lymph node in a patient with von Willebrand disease after multiple blood transfusions. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2014 May;60(1):73-5. doi: 10.1016/j.jcv.2014.02.007. Epub 2014 Feb 24.
2014
AOU Novara

Boldorini R; Allegrini S; Tognon M; Miglio U; Rossi D; Pawlita M; Viscidi R;

CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Mar 20;32(9):897-904. doi: 10.1200/JCO.2013.50.8515. Epub 2014 Feb 10.
2014
AOU Novara

Bulian P; Shanafelt TD; Fegan C; Zucchetto A; Cro L; Nückel H; Baldini L; Kurtova AV; Ferrajoli A; Burger JA; Gaidano G; Del Poeta G; Pepper C; Rossi D; Gattei V;

Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial. in Leukemia / Leukemia. 2014 Mar;28(3):642-8. doi: 10.1038/leu.2013.334. Epub 2013 Nov 13.
2014
AOU Novara

Cortelezzi A; Sciumè M; Liberati AM; Vincenti D; Cuneo A; Reda G; Laurenti L; Zaja F; Marasca R; Chiarenza A; Gritti G; Orsucci L; Storti S; Angelucci E; Cascavilla N; Gobbi M; Mauro FR; Morabito F; Fabris S; Piciocchi A; Vignetti M; Neri A; Rossi D; Giannarelli D; Guarini A; Foà R;

Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study. in Blood / Blood. 2014 Jul 3;124(1):63-9. doi: 10.1182/blood-2014-03-563759. Epub 2014 May 22.
2014
AOU Città della Salute di Torino
AOU Novara

Boccadoro M; Caravita T; Tacchetti P; Oliva S; Montefusco V; Genuardi M; Benevolo G; Ciccone G; Gentilini F; Offidani M; Omedé P; Boccadifuoco L; Musto P; Magarotto V; Rossi D; Conticello C; Larocca A; Petrucci MT; Bringhen S; Sonneveld P; Palumbo A;

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2013 Nov 1;19(21):5890-900. doi: 10.1158/1078-0432.CCR-13-0622. Epub 2013 Sep 13.
2013
AOU Novara

Massucco C; Recchia AG; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Mosca L; Morabito F; Colombo M; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; et alii...

Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma. in Cancer / Cancer. 2010 May 1;116(9):2188-200. doi: 10.1002/cncr.24959.
2010
AOU Novara

Rossi D; Fangazio M; De Paoli L; Puma A; Riccomagno P; Pinto V; Zigrossi P; Ramponi A; Monga G; Gaidano G;

Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature. in Cancer genetics and cytogenetics / Cancer Genet Cytogenet. 2010 Jan 1;196(1):89-92. doi: 10.1016/j.cancergencyto.2009.07.003.
2010
AOU Novara

Lunghi M; Casorzo L; De Paoli L; Riccomagno P; Rossi D; Gaidano G;

Richter syndrome: molecular insights and clinical perspectives. in Hematological oncology / Hematol Oncol. 2009 Mar;27(1):1-10. doi: 10.1002/hon.880.
2009
AOU Novara

Rossi D; Gaidano G;

The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. in British journal of haematology / Br J Haematol. 2009 Jun;146(1):64-75. doi: 10.1111/j.1365-2141.2009.07711.x. Epub 2009 May 5.
2009
AOU Novara

Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F;

The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2009 Feb 1;15(3):995-1004. doi: 10.1158/1078-0432.CCR-08-1630.
2009
AOU Novara

Rossi D; Cerri M; Deambrogi C; Sozzi E; Cresta S; Rasi S; De Paoli L; Spina V; Gattei V; Capello D; Forconi F; Lauria F; Gaidano G;

Bone marrow necrosis complicating post-transplant lymphoproliferative disorder: resolution with rituximab. in Leukemia research / Leuk Res. 2008 May;32(5):829-34. doi: 10.1016/j.leukres.2007.10.007. Epub 2007 Nov 26.
2008
AOU Novara

Rossi D; Ramponi A; Franceschetti S; Stratta P; Gaidano G;

Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. in British journal of haematology / Br J Haematol. 2008 Jun;142(2):202-15. doi: 10.1111/j.1365-2141.2008.07166.x. Epub 2008 May 19.
2008
AOU Novara

Rossi D; Cerri M; Capello D; Deambrogi C; Rossi FM; Zucchetto A; De Paoli L; Cresta S; Rasi S; Spina V; Franceschetti S; Lunghi M; Vendramin C; Bomben R; Ramponi A; Monga G; Conconi A; Magnani C; Gattei V; Gaidano G;

Simultaneous diagnosis of CD3+ T-cell large granular lymphocyte leukaemia and true thymic hyperplasia. in Leukemia research / Leuk Res. 2007 Jul;31(7):1019-21. doi: 10.1016/j.leukres.2006.10.019. Epub 2006 Nov 29.
2007
AOU Novara

Rossi D; Franceschetti S; Capello D; Conconi A; Casadio C; Valente G; Gaidano G;

Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance. in British journal of haematology / Br J Haematol. 2007 Jul;138(2):249-52. doi: 10.1111/j.1365-2141.2007.06633.x. Epub 2007 May 29.
2007
AOU Novara

Rossi D; De Paoli L; Franceschetti S; Capello D; Vendramin C; Lunghi M; Conconi A; Magnani C; Gaidano G;

Transient monoclonal expansion of CD8+/CD57+ T-cell large granular lymphocytes after primary cytomegalovirus infection. in American journal of hematology / Am J Hematol. 2007 Dec;82(12):1103-5. doi: 10.1002/ajh.20981.
2007
AOU Novara

Rossi D; Franceschetti S; Capello D; De Paoli L; Lunghi M; Conconi A; Gaidano G;